When sleep upheavals continue for more than two weeks and begin to pose problems in an individual’s life, they can become a concern, especially in the case of patients of bipolar disorder (BD). A recent study, published in the British Journal of Psychiatry, sheds light on the importance of sound sleep for bipolar patients. One […]
The Food and Drug Administration (FDA) has approved the extended-release formulation of aripiprazole (Abilify Maintena) as an injectable suspension for maintenance monotherapy treatment of bipolar 1 disorder (BP-1) in adults. Abilify Maintena is an atypical antipsychotic, developed jointly by Otsuka Pharmaceutical Co, Ltd, in Japan and H. Lundbeck A/S, a Danish international pharmaceutical company. It […]
Millions of Americans each year are diagnosed with some kind of mental disorder, including depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), among others. According to the National Alliance on Mental Illness (NAMI), roughly 18.5 percent adults in the United States experience mental illness in any given year. Since 1949, every year […]
Bipolar disorder is a mental illness marked by episodes of depression and mania, affecting 1 percent people across the world. Also known as manic-depressive illness, it is a brain disorder causing drastic upheavals in the mood, activity levels and energy, coupled with an impaired ability to accomplish mundane everyday chores. It is more prevalent among […]
Chat Live Now!
24/7 Helpline
